As health reform continues to mature, questions continue to swirl in the minds of pharmaceutical executives: How will health policy changes affect my business? How will they affect my key stakeholders? In the case of prescribers, health reform initiatives hold the potential to create significant adjustments to how and what care is delivered to Medicare beneficiaries.
Join us on Thursday, July 22 at 2PM (Eastern) for the fourth presentation in our five-part series, “Ensuring Patient Access in the Evolving Healthcare Market.” In part four, our speakers will discuss how the Physician Quality Reporting Initiative (PQRI) may pose significant challenges to healthcare providers--and how it could impact patient access to care. This program will explore what manufacturers can do to develop a proactive, collaborative response to these challenges.
Other topics to be covered include:
PRESENTERS
Doug Neely, CMPE, MHA
Director
Xcenda
Donna Gilbert
Senior Director
Xcenda
MODERATOR
Peyton Howell, MHA
President, Consulting Services
AmerisourceBergen Corp.